3 insiders reported 5 Form 4 transactions for ArriVent BioPharma, Inc. (AVBP) over the past 18 months (most recent 2026-02-03). Recent activity: HILLHOUSE INVESTMENT MANAGEMENT, LTD. (Insider) Sell 555,555 shares, HHLR ADVISORS, LTD. (Insider) Sell 555,555 shares, LaChapelle Robin (Chief Operating Officer) Buy 2,050 shares, LaChapelle Robin (Chief Operating Officer) Buy 2,600 shares, LaChapelle Robin (Chief Operating Officer) Buy 6,503 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Insider | Sell | 555,555 | $13.0M |
| 2026-02-03 | HHLR ADVISORS, LTD. | Insider | Sell | 555,555 | $13.0M |
| 2025-07-15 | LaChapelle Robin | Chief Operating Officer | Buy | 2,050 | $4,674 |
| 2025-07-15 | LaChapelle Robin | Chief Operating Officer | Buy | 2,600 | $5,928 |
| 2025-07-15 | LaChapelle Robin | Chief Operating Officer | Buy | 6,503 | $14,827 |
Source: SEC Form 4 filings · as of 2026-02-03